Post by brentie on Aug 18, 2013 21:49:44 GMT -5
OK, a couple of days have passed, I think I can start posting articles again.
"MannKind is another company that took a hit on late-stage trial news, but this announcement was initially taken as a positive. Shares of MannKind popped higher announcing positive efficacy results for its inhalable insulin treatment for both primary types of diabetes.
It could have been a case of "sell on the news" kicking in. Impatient investors also may have gotten cold feet, since regulatory approval won't be completed until next year at the earliest.
There were also a couple of small negatives. The type 2 diabetes study found the majority of its Afrezza-inhaling test subjects experiencing low blood sugar. The type 1 diabetes results achieved target levels that weren't as effective as injection-based insulin that's already on the market.
In the end, these may be just minor setbacks given the clear appeal of needle-free insulin. It wouldn't be a surprise to see MannKind bounce back after the largely positive report."
www.freenewspos.com/news/article/a/657276/today/5-of-last-week-39-s-biggest-losers
"MannKind is another company that took a hit on late-stage trial news, but this announcement was initially taken as a positive. Shares of MannKind popped higher announcing positive efficacy results for its inhalable insulin treatment for both primary types of diabetes.
It could have been a case of "sell on the news" kicking in. Impatient investors also may have gotten cold feet, since regulatory approval won't be completed until next year at the earliest.
There were also a couple of small negatives. The type 2 diabetes study found the majority of its Afrezza-inhaling test subjects experiencing low blood sugar. The type 1 diabetes results achieved target levels that weren't as effective as injection-based insulin that's already on the market.
In the end, these may be just minor setbacks given the clear appeal of needle-free insulin. It wouldn't be a surprise to see MannKind bounce back after the largely positive report."
www.freenewspos.com/news/article/a/657276/today/5-of-last-week-39-s-biggest-losers